The development of nanocarriers for drug delivery has revolutionized the field of nanomedicine, promising enhanced therapeutic efficacy and targeted action. However, concerns regarding biocompatibility and safety remain significant barriers to their clinical translation. This article reviews the current challenges associated with the biocompatibility and safety of nanocarriers, discusses the mechanisms of toxicity, and outlines strategies for mitigating risks. We highlight recent advancements in materials science, surface modification techniques, and regulatory frameworks aimed at ensuring the safe application of nanocarriers in medical therapies.
Published Date: 2024-09-30; Received Date: 2024-09-03